According to NRC Health 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 7.5026. At the end of 2023 the company had a P/S ratio of 7.21.
Year | P/S ratio | Change |
---|---|---|
2023 | 7.21 | 18.69% |
2022 | 6.08 | -14.62% |
2021 | 7.12 | -12.61% |
2020 | 8.14 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
![]() Nymox Pharmaceutical NYMX | N/A | N/A | Bahamas |
![]() NRC Health
NRC | 7.50 | 0.00% | ๐บ๐ธ USA |